CVE & CISA-KEV Catalog

CVE-2020-16228

MEDIUM
6.4
CVSS v3
NVD

Description

In Patient Information Center iX (PICiX) Versions C.02 and C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX550, MX750, MX850, and IntelliVue X3 Versions N and prior, the software does not check or incorrectly checks the revocation status of a certificate, which may cause it to use a compromised certificate.

How to fix

No published remediation has been found for this vulnerability's affected products yet.

Mitigation guidance may be in the linked vendor advisories in the References section below.

CVSS v3 Vector

Exploitability

Attack VectorAdjacent
Attack ComplexityLow
Privileges RequiredHigh
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityHigh
AvailabilityLow

CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:L

Exploit Intelligence

0.37%probability of exploitation in 30 days
29thpercentile

Low risk: more likely to be exploited than 29% of all known CVEs.

References

Third-Party Advisory1
Other references1
Embed a live status badge for CVE-2020-16228
CVE-2020-16228 severity badge

Markdown

[![CVE-2020-16228](https://tridentstack.com/cve/badge/CVE-2020-16228.svg)](https://tridentstack.com/cve/CVE-2020-16228)

HTML

<a href="https://tridentstack.com/cve/CVE-2020-16228"><img src="https://tridentstack.com/cve/badge/CVE-2020-16228.svg" alt="CVE-2020-16228"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-02-23.